SC 13G/A: Pharvaris N.V.
Ticker: PHVS · Form: SC 13G/A · Filed: 2024-02-14T00:00:00.000Z
Sentiment: neutral
Topics: sc-13g-a
AI Summary
SC 13G/A filing by Pharvaris N.V..
Risk Assessment
Risk Level: low
From the Filing
0000905148-24-000627.txt : 20240214 0000905148-24-000627.hdr.sgml : 20240214 20240214102718 ACCESSION NUMBER: 0000905148-24-000627 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240214 DATE AS OF CHANGE: 20240214 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Pharvaris N.V. CENTRAL INDEX KEY: 0001830487 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: P7 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-92181 FILM NUMBER: 24633716 BUSINESS ADDRESS: STREET 1: J.H. OORTWEG 21 STREET 2: 2333 CH LEIDEN CITY: LEIDEN STATE: P7 ZIP: 00000 BUSINESS PHONE: 31 (0)71 203 6410 MAIL ADDRESS: STREET 1: J.H. OORTWEG 21 STREET 2: 2333 CH LEIDEN CITY: LEIDEN STATE: P7 ZIP: 00000 FORMER COMPANY: FORMER CONFORMED NAME: Pharvaris, B.V. DATE OF NAME CHANGE: 20201029 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: VIKING GLOBAL INVESTORS LP CENTRAL INDEX KEY: 0001103804 ORGANIZATION NAME: IRS NUMBER: 134055118 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 600 WASHINGTON BLVD. STREET 2: FLOOR 11 CITY: STAMFORD STATE: CT ZIP: 06901 BUSINESS PHONE: 212-672-7050 MAIL ADDRESS: STREET 1: 600 WASHINGTON BLVD. STREET 2: FLOOR 11 CITY: STAMFORD STATE: CT ZIP: 06901 SC 13G/A 1 sayw24021416_13ga.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   SCHEDULE 13G INFORMATION TO BE INCLUDED IN STATEMENTS PURSUANT TO RULES 13d- 1(b),(c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO 13d-2 UNDER THE SECURITIES EXCHANGE ACT OF 1934*   (Amendment No. 3) Pharvaris N.V. (Name of Issuer) Ordinary shares, par value €0.12 par value per share (Title of Class of Securities) N69605108 (CUSIP Number) December 31, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☐ Rule 13d-1(b) ☒ Rule 13d-1(c) ☐ Rule 13d-1(d) * The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes ) CUSIP No. N69605108 13G Page 2 of 16 1 NAMES OF REPORTING PERSONS     Viking Global Investors LP         2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP     (a)☐     (b)☒     3 SEC USE ONLY               4 CITIZENSHIP OR PLACE OF ORGANIZATION     Delaware         NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5 SOLE VOTING POWER     0         6 SHARED VOTING POWER     3,656,923*         7 SOLE DISPOSITIVE POWER     0         8 SHARED DISPOSITIVE POWER     3,656,923*         9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON     3,656,923*         10 CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)*     ☐         11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)     7.0%*         12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)     PN         * See Item 4 CUSIP No. N69605108 13G Page 3 of 16 1 NAM